Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study

J Gerontol A Biol Sci Med Sci. 2001 Feb;56(2):M75-8. doi: 10.1093/gerona/56.2.m75.

Abstract

Background: Whether and which genetic factors affect human longevity is unclear. This study assesses the association between the epsilon2 allele of apolipoprotein E (APOE), a putative longevity gene, and extremely old age.

Methods: This study is based on all centenarians living in Finland in 1991. Subjects were 179 persons (28 men and 151 women) aged 100 years and older (response rate, 97%).

Results: The percentages of epsilon2-allele carriers in persons aged 100 to 101, 102 to 103, and 104 years and older were 9% (10/117), 21% (9/42), and 25% (5/20; gender-adjusted p for trend = .01), respectively. The effect was particularly strong in women: 8% (8/100), 18% (6/33), and 28% (5/18; p for trend = .01) by age group, respectively. Low cell numbers prevented clear conclusions being drawn for men. Seventeen percent (30/179) of the adult Finnish population were carriers of the epsilon4 allele, a figure lower than expected, and stable by age group.

Conclusions: Carriers of the epsilon2 allele of APOE might be predisposed to reach extremely old age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Apolipoprotein E2
  • Apolipoproteins E / genetics*
  • Female
  • Finland
  • Gene Frequency
  • Genotype
  • Humans
  • Longevity*
  • Male
  • Odds Ratio
  • Regression Analysis
  • Sex Characteristics

Substances

  • Apolipoprotein E2
  • Apolipoproteins E